Popular search terms:
Search Results
117 results found-
Product Orders
CSL Behring Australia is a biopharmaceutical leader driven by its promise to save and improve lives. We manufacture remedies for rare and serious conditions.
https://www.cslbehring.com.au/product-orders -
Products List
CSL Behring provides protein-based therapies for bleeding disorders, critical care, pulmonary disease, and other rare illnesses.
https://www.cslbehring.com.au/products/products-list -
Our Products | CSL Behring Australia
CSL Behring provides protein-based therapies for bleeding disorders, critical care, pulmonary disease, and other rare illnesses.
https://www.cslbehring.com.au/products -
Marketing Statement
CSL Behring Australia is a biopharmaceutical leader driven by its promise to save and improve lives. We manufacture remedies for rare and serious conditions.
https://www.cslbehring.com.au/marketing-statement -
Graduate Streams
CSL Behring's Graduate Program Home Page
https://www.cslbehring.com.au/careers/graduate-program/graduate-streams -
Our Company | CSL Behring Australia
CSL Behring is a global biotech company leading the way to deliver innovative therapies for rare and serious diseases.
https://www.cslbehring.com.au/our-company -
PowerPoint Presentation
R&D Investor Briefing December 4, 2019 After struggling for years to get an accurate diagnosis, hereditary Legal Notice angioedema (HAE) patient Kathrin Schoen is working to ensure Forward looking statements the next generation of The materials in this presentation speak only as of the date of these materials, and include forward looking patients doesn't have statements about CSL Limited and its related bodies corporate (CSL) financial results and estimates, to wait so long. business prospects and products in research, all of which involve substantial risks and uncertainties, many of which are outside the control of, and are unknown to, CSL.
https://www.cslbehring.com.au/-/media/shared/documents/7/rd-investor-briefing-2019.pdf -
NEW ZEALAND DATA SHEET 1 PRODUCT NAME Prothrombinex®-VF powder and diluent for solution for injection 2 QUALITATIVE AND QUANTITA...
The risk that such products will transmit an infectious agent has been reduced by screening plasma donors for prior exposure to certain infectious agents and by testing for the presence of certain viral markers.
https://www.cslbehring.com.au/-/media/cslb-australia/documents/nz-dss/prothrombinexvf-nz-ds-2000.pdf -
HCP App Terms of Use
CSL Behring Australia is a biopharmaceutical leader driven by its promise to save and improve lives. We manufacture remedies for rare and serious conditions.
https://www.cslbehring.com.au/hcp-app-terms-of-use -
Riastap Data Sheet
Resulting from these studies, as well as from long lasting clinical experience with fibrinogen products, dosage recommendations in the treatment of children are the same as for adults.
https://www.cslbehring.com.au/-/media/cslb-australia/documents/nz-dss/riastap-nz-ds-v900-with-wfi.pdf